Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

SK Pharm and Hanmi Pharm Will Bring Epilepsy Treatment to China

publication date: Apr 25, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Two Korean biopharmas, SK Biopharmaceuticals and Hanmi Pharm, announced a strategic partnership to bring an epilepsy drug to China and Korea. SK Biopharm developed the drug – the seizure control and muscle relaxant treatment diazepam, which is delivered by a nasal spray. Hanmi’s China subsidiary will be in charge of obtaining SFDA approval for the drug and marketing it in China and Korea. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Event Updates
Greg Scott will be attending and speaking at these events:
 
 
 
Hope to see you there!
 
ChinaBio® Events
More events coming soon...

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors